(Q47895125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Developmental timing and critical windows for the treatment of psychiatric disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Oscar Marín

series ordinal

1

1 reference

http://europepmc.org/abstract/MED/27783067

6 February 2018

language of work or name

English

0 references

publication date

26 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

1229-1238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.4225

26 March 2020

exact match

0 references

cites work

Global burden of disease in young people aged 10-24 years: a systematic analysis

1 reference

Mental health. Adolescent mental health--opportunity and obligation

21 January 2018

1 reference

21 January 2018

1 reference

Clinical trials for neurodevelopmental disorders: At a therapeutic frontier.

21 January 2018

1 reference

Functional and evolutionary insights into human brain development through global transcriptome analysis

21 January 2018

1 reference

Developmental regulation of human cortex transcription and its clinical relevance at single base resolution

21 January 2018

1 reference

Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity

21 January 2018

1 reference

Autism spectrum disorders: from genes to neurobiology

21 January 2018

1 reference

Schizophrenia risk from complex variation of complement component 4

21 January 2018

1 reference

The impact of environmental factors in severe psychiatric disorders

21 January 2018

1 reference

Neuronal plasticity: beyond the critical period

21 January 2018

1 reference

Development of pattern vision following early and extended blindness

21 January 2018

1 reference

Altering the course of schizophrenia: progress and perspectives

21 January 2018

1 reference

Intervention in the context of development: pathways toward new treatments

21 January 2018

1 reference

The Cellular and Molecular Landscapes of the Developing Human Central Nervous System

21 January 2018

1 reference

NEURODEVELOPMENT. Adult cortical plasticity depends on an early postnatal critical period.

21 January 2018

1 reference

Assessing executive function in preschoolers.

21 January 2018

1 reference

Critical period for first language: the crucial role of language input during the first year of life

21 January 2018

1 reference

Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness

21 January 2018

1 reference

Activity-dependent neuronal signalling and autism spectrum disorder

21 January 2018

1 reference

Dendritic spine pathology in neuropsychiatric disorders

21 January 2018

1 reference

Neuroligins and neurexins link synaptic function to cognitive disease

21 January 2018

1 reference

Excitatory actions of gaba during development: the nature of the nurture

21 January 2018

1 reference

GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations

21 January 2018

1 reference

A role for correlated spontaneous activity in the assembly of neural circuits

21 January 2018

1 reference

Neural synchrony and the development of cortical networks.

21 January 2018

1 reference

Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery.

21 January 2018

1 reference

Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review

21 January 2018

1 reference

Is birth a critical period in the pathogenesis of autism spectrum disorders?

21 January 2018

1 reference

Sparsification of neuronal activity in the visual cortex at eye-opening

21 January 2018

1 reference

A theory of the transition to critical period plasticity: inhibition selectively suppresses spontaneous activity

21 January 2018

1 reference

Regulating critical period plasticity: insight from the visual system to fear circuitry for therapeutic interventions.

21 January 2018

1 reference

The period of susceptibility to the physiological effects of unilateral eye closure in kittens

21 January 2018

1 reference

Critical period plasticity matches binocular orientation preference in the visual cortex

21 January 2018

1 reference

Critical period plasticity in local cortical circuits

21 January 2018

1 reference

Interneurons. Fast-spiking, parvalbumin⁺ GABAergic interneurons: from cellular design to microcircuit function.

21 January 2018

1 reference

Hippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric Disease

21 January 2018

1 reference

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

Neurodevelopmental model of schizophrenia: update 2012

21 January 2018

1 reference

21 January 2018

Rethinking schizophrenia

1 reference

Neuroleptics and the Natural Course of Schizophrenia

21 January 2018

1 reference

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

21 January 2018

1 reference

Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies

21 January 2018

1 reference

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

21 January 2018

1 reference

Cortical inhibitory neurons and schizophrenia

21 January 2018

1 reference

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk

21 January 2018

1 reference

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.

21 January 2018

1 reference

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

21 January 2018

1 reference

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

21 January 2018

1 reference

Translating the MAM model of psychosis to humans

21 January 2018

1 reference

Animal models of schizophrenia.

21 January 2018

1 reference

Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity

21 January 2018

1 reference

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

Modeling psychiatric disorders for developing effective treatments

21 January 2018

1 reference

Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

21 January 2018

1 reference

Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

21 January 2018

1 reference

Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine

21 January 2018

1 reference

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

21 January 2018

1 reference

Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver

21 January 2018

1 reference

Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis

21 January 2018

1 reference

Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes.

21 January 2018

1 reference

Increased Resting-State Gamma-Band Connectivity in First-Episode Schizophrenia

21 January 2018

1 reference

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia.

21 January 2018

1 reference

Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia

21 January 2018

1 reference

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

21 January 2018

1 reference

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.

21 January 2018

1 reference

22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia

21 January 2018

1 reference

Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome

21 January 2018

1 reference

Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia

21 January 2018

1 reference

Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.

21 January 2018

1 reference

Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition.

21 January 2018

1 reference

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors.

21 January 2018

1 reference

Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia

21 January 2018

1 reference

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

21 January 2018

1 reference

Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons

21 January 2018

1 reference

N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Redox dysregulation, neurodevelopment, and schizophrenia

21 January 2018

1 reference

Exposure to enriched environments during adolescence prevents abnormal behaviours associated with histone deacetylation in phencyclidine-treated mice.

21 January 2018

1 reference

Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model

21 January 2018

1 reference

Advances in the treatment of fragile X syndrome

21 January 2018

1 reference

The pathophysiology of fragile x syndrome.

21 January 2018

1 reference

Molecular mechanisms of fragile X syndrome: a twenty-year perspective

21 January 2018

1 reference

The mGluR theory of fragile X mental retardation

21 January 2018

1 reference

21 January 2018

1 reference

Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice.

21 January 2018

1 reference

Delayed stabilization of dendritic spines in fragile X mice

21 January 2018

1 reference

Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.

21 January 2018

1 reference

Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice.

21 January 2018

1 reference

Correction of fragile X syndrome in mice.

21 January 2018

1 reference

Impaired critical period plasticity in primary auditory cortex of fragile X model mice

21 January 2018

1 reference

Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome.

21 January 2018

1 reference

Seizures in fragile X syndrome: characteristics and comorbid diagnoses

21 January 2018

1 reference

Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.

21 January 2018

1 reference

Circuit level defects in the developing neocortex of Fragile X mice

21 January 2018

1 reference

Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome

21 January 2018

1 reference

The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders

21 January 2018

1 reference

The developmental switch in GABA polarity is delayed in fragile X mice.

21 January 2018

1 reference

Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.

21 January 2018

1 reference

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

21 January 2018

1 reference

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

21 January 2018

1 reference

Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.

21 January 2018

1 reference

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome.

21 January 2018

1 reference

A randomised controlled trial of bumetanide in the treatment of autism in children

21 January 2018

1 reference

Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.

21 January 2018

1 reference

Treatment during a vulnerable developmental period rescues a genetic epilepsy.

21 January 2018

1 reference

The story of Rett syndrome: from clinic to neurobiology

21 January 2018

1 reference

Clinical manifestations and stages of Rett syndrome

21 January 2018

1 reference

MeCP2: the long trip from a chromatin protein to neurological disorders

21 January 2018

1 reference

Rett Syndrome: Crossing the Threshold to Clinical Translation

21 January 2018

1 reference

MECP2 disorders: from the clinic to mice and back

21 January 2018

1 reference

NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.

21 January 2018

1 reference

MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex

21 January 2018

1 reference

Cell-Specific Regulation of N-Methyl-D-Aspartate Receptor Maturation by Mecp2 in Cortical Circuits.

21 January 2018

1 reference

BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.

21 January 2018

1 reference

Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome

21 January 2018

1 reference

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

21 January 2018

1 reference

Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype

21 January 2018

1 reference

Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment

21 January 2018

1 reference

Reversing neurodevelopmental disorders in adults

21 January 2018

1 reference

Adult neural function requires MeCP2.

21 January 2018

1 reference

Intervention for infants at risk of developing autism: a case series

21 January 2018

1 reference

Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial

21 January 2018

1 reference

Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study

21 January 2018

1 reference

Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis.

21 January 2018

1 reference

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis.

21 January 2018

1 reference

HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia

21 January 2018

1 reference

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project

21 January 2018

1 reference

Glutamate and psychosis risk

21 January 2018

1 reference

Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis

21 January 2018

1 reference

Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis

21 January 2018

1 reference

Differences in white matter fiber tract development present from 6 to 24 months in infants with autism

21 January 2018

1 reference

Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism

21 January 2018

1 reference

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents

21 January 2018

1 reference

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

21 January 2018

1 reference

Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

21 January 2018

1 reference

Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.

21 January 2018

1 reference

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome

21 January 2018

1 reference

Age of onset of mental disorders: a review of recent literature

21 January 2018

1 reference

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

21 January 2018

1 reference

Schizophrenia: The making of a troubled mind

21 January 2018

1 reference

GABAergic interneurons shape the functional maturation of the cortex

21 January 2018

1 reference

Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

21 January 2018

1 reference

12 December 2020

Interneuron dysfunction in psychiatric disorders

1 reference

12 December 2020

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients

1 reference

12 December 2020

Abnormal development of dendritic spines in FMR1 knock-out mice

1 reference

12 December 2020

Long-Term Enhancement of Neuronal Excitability and Temporal Fidelity Mediated by Metabotropic Glutamate Receptor Subtype 5

1 reference

12 December 2020

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial

1 reference

12 December 2020

Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative

1 reference

12 December 2020

Extent of recovery from the effects of visual deprivation in kittens

1 reference

12 December 2020

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.4225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783067%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference